Department of Experimental Medicine, Sapienza University of Rome, 00161, Rome, Italy; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, 00161, Rome, Italy.
UOC Immunohematology and Transfusional Medicine, Policlinico Umberto I, Rome, Italy.
Virus Res. 2021 Jan 15;292:198231. doi: 10.1016/j.virusres.2020.198231. Epub 2020 Nov 15.
Programmed death ligand 1 (PD-L1) up-regulation on antigen presenting cells induces T cell dysfunction, strongly impairing immune response. Human Herpesviruses (HHV) 6B is a β-herpesvirus that, although displays a higher tropism for T cells, can infect other immune cells including monocytes and dendritic cells (DCs) and neuronal cells. We have previously shown that HHV-6B infection of primary monocytes reduced autophagy and induced Endoplasmic Reticulum (ER) stress/ Unfolded Protein Response (UPR), impairing their survival and differentiation into DCs. In this study, we found that PD-L1 expression was up-regulated by HHV-6B on the surface of infected monocytes and that its extracellular release also increased, effects known to lead to an impairment of anti-viral immune response. At molecular level, PD-L1 up-regulation correlated with the activation of a positive regulatory circuit between the increase of intracellular ROS and the activation of STAT1 and STAT3 induced by HHV-6B, accompanied by a high release of pro-inflammatory/immune suppressive cytokines. In conclusion, this study unveils new strategies put in place by HHV-6B to induce immune dysfunction and the underlying molecular pathways that could be targeted to counteract such immune suppressive effects.
程序性死亡配体 1(PD-L1)在抗原呈递细胞上的上调诱导 T 细胞功能障碍,强烈损害免疫反应。人类疱疹病毒 6B(HHV-6B)是一种β疱疹病毒,尽管它对 T 细胞具有更高的嗜性,但也可以感染其他免疫细胞,包括单核细胞和树突状细胞(DC)和神经元细胞。我们之前已经表明,HHV-6B 感染原代单核细胞会减少自噬并诱导内质网(ER)应激/未折叠蛋白反应(UPR),从而损害其存活和分化为 DC 的能力。在这项研究中,我们发现 HHV-6B 在感染单核细胞的表面上调 PD-L1 的表达,并且其细胞外释放也增加,这些已知的效应会导致抗病毒免疫反应受损。在分子水平上,PD-L1 的上调与 HH6B 诱导的细胞内 ROS 增加与 STAT1 和 STAT3 的激活之间的正调节回路的激活相关,同时伴有促炎/免疫抑制细胞因子的大量释放。总之,这项研究揭示了 HHV-6B 诱导免疫功能障碍的新策略及其潜在的分子途径,这些途径可能成为对抗这种免疫抑制作用的靶点。